A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation
Section snippets
Acknowledgements
We thank Dr. N. Suzuki and A. Asami-Odaka (Takeda Pharmaceutical Co., Japan) for providing antibodies BAN-50, BA-27, and BC-05. This work was partly supported by grants to H.T. from the Japanese Ministry of Education, Culture, Science and Sports (17590242).
References (18)
- et al.
A splice variant of β-secretase deficient in the amyloidogenic processing of the amyloid precursor protein
J. Biol. Chem.
(2001) - et al.
Maturation and pro-peptide cleavage of beta-secretase
J. Biol. Chem.
(2000) - et al.
Splice variants of the β-site APP-cleaving enzyme BACE1 in human brain and pancreas
Biochem. Biophys. Res. Commun.
(2002) - et al.
Characterization of Alzheimer's beta-secretase protein BACE. A pepsin family member with unusual properties
J. Biol. Chem.
(2000) - et al.
Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme: the Alzheimer's disease beta-secretase
J. Biol. Chem.
(2000) - et al.
Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production
Neurosci. Lett.
(2001) - et al.
Molecular analysis of the presenilin 1 (S182) gene in “Sporadic” cases of Alzheimer's disease: Identification and characterization of unusual splice variants
J. Neurochem.
(1996) - et al.
Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice form
Mol. Psychiatry
(2003) - et al.
Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease
J. Neurochem.
(2003)
Cited by (11)
Rhomboid protease RHBDL4 promotes retrotranslocation of aggregation-prone proteins for degradation
2022, Cell ReportsCitation Excerpt :This suggests that RHBDL4 shows substrate specificity. As a follow-up, we tested two additional ERAD substrates resembling truncated type I membrane proteins, namely RI332, a deletion of ribophorin 1 (RPN1) (Tsao et al., 1992), and a loss-of-function splice variant of the β-secretase (BACE476Δ) (Tanahashi and Tabira, 2007). BACE476Δ was cleaved by ectopically expressed RHBDL4 leading to a 50-kDa fragment that appears between the glycosylated full-length 54-kDa form of BACE476Δ and the MG132-stabilized 45-kDa deglycosylated species (Figures 3B and S3A).
Expression analysis of human β-secretase in transgenic tomato fruits
2012, Protein Expression and PurificationCitation Excerpt :Alzheimer’s disease (AD1) is a neurodegenerative disease characterized by the progressive formation of neuritic plaques in the brain. These highly insoluble, plastic-like deposits are composed of a 4-kDa β-amyloid protein (Aβ) derived from the amyloid precursor protein (APP) by sequential proteolysis of β-secretase and γ-secretase [1,2]. First, β-secretase cleaves APP to generate the N terminus of Aβ; next, γ-secretase cleaves the C terminus, leading to the release of Aβ [3].
Promotion of BACE1 mRNA alternative splicing reduces amyloid β-peptide production
2008, Journal of Biological ChemistryCitation Excerpt :Additional alternative splicing of BACE1 RNA could result in the production of protein isoforms with varying levels of activity or rapid degradation of an unstable transcript. Indeed, a splice variant of BACE1 regulated by nonsense-mediated mRNA decay has recently been identified (31). Previous attempts to determine the activity of BACE1 476 and BACE1 457 have been inconclusive (25–27).
BACE1: More than just a β-secretase
2022, Obesity ReviewsSplice variants of the Alzheimer's disease beta-secretase, BACE1
2013, NeurogeneticsTailoring of membrane proteins by alternative splicing of Pre-mRNA
2012, Biochemistry